These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Wallerox increases cerebral circulation and heart capacity]. Heynen U. Z Allgemeinmed; 1971 Dec 10; 47(34):1823-5. PubMed ID: 5003212 [No Abstract] [Full Text] [Related]
4. [Conservative treatment of cerebral insufficiency. Experiences with wallerox]. Poser G. Munch Med Wochenschr; 1971 May 07; 113(19):738-41. PubMed ID: 4995708 [No Abstract] [Full Text] [Related]
5. [Changes of the cerebral circulation time influenced by hydergine]. Herzfeld U, Wittgen M. Arztl Forsch; 1971 Jul 10; 25(7):224-30. PubMed ID: 4998670 [No Abstract] [Full Text] [Related]
6. [Clinical experiences with gerontotherapeutic agent Wallerox (GN 468)]. Voegt H, Haid E. Med Klin; 1970 Nov 13; 65(46):2031-5. PubMed ID: 5000077 [No Abstract] [Full Text] [Related]
13. [Aescin (=Reparil) in cerebral circulation disorders. Clinical and ophthalmodynamographic observations]. Tzavellas O, Finke J. Wien Klin Wochenschr; 1970 Oct 09; 82(41):714-6. PubMed ID: 5529668 [No Abstract] [Full Text] [Related]